C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/48 (2006.01) C12N 15/63 (2006.01) C12N 15/64 (2006.01) C12N 15/867 (2006.01)
Patent
CA 2360858
The present invention is a method of generating retro- viral vector particles derived from retroviruses and capable of transducing therapeutic genes into non-dividing cells. Mutations made in the retroviral matrix protein (MA) enable infection of non-dividing cells.
L'invention concerne une technique de production de particules de vecteur rétroviral dérivées de rétrovirus, et capables de transduire des gènes thérapeutiques en cellules ne se divisant pas. Les mutations de la protéine à matrice (MA) rétrovirale permettent l'infection desdites cellules ne se divisant pas.
Dornburg Ralph
Gowling Lafleur Henderson Llp
Thomas Jefferson University
LandOfFree
Genetically engineered retroviral vector particles capable... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically engineered retroviral vector particles capable..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered retroviral vector particles capable... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1743914